Arbutus Biopharma Corporation ABUS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent?
- Arbutus Biopharma Corporation (ABUS) reported comprehensive income (loss), net of tax, attributable to parent of $169.6M in Q1 2026.
- How has Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent increased by 790.6% year-over-year, from -$24.56M to $169.6M.
- What is the long-term trend for Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's comprehensive income (loss), net of tax, attributable to parent has grown at a -18.7% compound annual growth rate (CAGR), from -$76.45M to -$33.46M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric measures the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities and foreign currency translation adjustments. It provides a more holistic view of the company's financial performance by capturing volatility that is excluded from the traditional net income statement. This figure is essential for evaluating the total economic impact of market fluctuations on the company's net assets.